Lindbrook Capital, LLC Exact Sciences Corp Transaction History
Lindbrook Capital, LLC
- $1.09 Billion
- Q4 2024
A detailed history of Lindbrook Capital, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 507 shares of EXAS stock, worth $25,649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
507
Previous 497
2.01%
Holding current value
$25,649
Previous $33,000
15.15%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding EXAS
# of Institutions
665Shares Held
156MCall Options Held
2.38MPut Options Held
2M-
Capital World Investors Los Angeles, CA17.5MShares$887 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$861 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$610 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$610 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$315 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.95B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...